These ingredients are ideal for inflammatory skin conditions like eczema and psoriasis because they can help relieve itchiness, dryness and scaling on the skin. To strengthen your skin barrier ...

Background: Psoriasis is a chronic inflammatory skin disease with a genetic predisposition and autoimmune component, often treated with immunomodulators such as biologic therapies. Objectives: In this ...

Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her symptoms, you know that the skin condition is far from glamorous and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. By week 8, patients treated with roflumilast saw ...

Now, a study from Michel Gilliet's laboratory shows that the antimicrobial peptide LL37 is responsible for activation of pDCs in psoriasis. Knowing that pDCs are activated in psoriasis ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The aim of the present study was to measure full epidermal thickness, stratum corneum thickness, rete length, dermal papilla widening and suprapapillary epidermal thickness in psoriasis patients using ...

Using makeup can be a great way to camouflage psoriasis lesions. Try these tips for days when you want some coverage. People use makeup for all sorts of reasons: to play up certain facial features ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Between 61% to 82% of patients with atopic dermatitis, psoriasis, and xerosis reported improvement in their symptoms following 4 weeks of using a ceramide-containing skin care regimen. Researchers ...

77% of genital psoriasis patients saw clear/almost clear skin vs. 21% on placebo after 16 weeks. PN-881 showed 70x greater potency than secukinumab in vitro and effective reduction in skin ...

66% of patients with scalp psoriasis achieved a scalp-specific Investigator's Global Assessment (ss-IGA) c score of 0/1 compared to 11% receiving placebo (P<0.001) at 16 weeks.